 Joseph Rosenthal
Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 4 | 2016 | 297 | 0.950 |
Why?
| | Antibodies, Bacterial | 3 | 2016 | 119 | 0.700 |
Why?
| | Brain Ischemia | 4 | 2022 | 297 | 0.610 |
Why?
| | Bacterial Vaccines | 2 | 2016 | 61 | 0.590 |
Why?
| | Bacterial Outer Membrane Proteins | 2 | 2016 | 58 | 0.590 |
Why?
| | Antigens, Bacterial | 2 | 2016 | 111 | 0.580 |
Why?
| | Fatigue | 2 | 2016 | 294 | 0.580 |
Why?
| | Neurological Rehabilitation | 1 | 2016 | 5 | 0.540 |
Why?
| | Models, Neurological | 1 | 2016 | 212 | 0.470 |
Why?
| | Th1 Cells | 1 | 2014 | 123 | 0.450 |
Why?
| | Vaccines, Virus-Like Particle | 1 | 2013 | 3 | 0.450 |
Why?
| | Seizures | 1 | 2016 | 337 | 0.430 |
Why?
| | Stroke | 4 | 2022 | 1019 | 0.430 |
Why?
| | Drug Carriers | 1 | 2013 | 112 | 0.420 |
Why?
| | Escherichia coli | 3 | 2016 | 723 | 0.410 |
Why?
| | Sports | 1 | 2014 | 187 | 0.390 |
Why?
| | Population Surveillance | 1 | 2014 | 385 | 0.370 |
Why?
| | Blindness, Cortical | 1 | 2011 | 5 | 0.370 |
Why?
| | Autonomic Dysreflexia | 1 | 2011 | 4 | 0.370 |
Why?
| | Quadriplegia | 1 | 2011 | 12 | 0.370 |
Why?
| | Athletes | 1 | 2014 | 328 | 0.370 |
Why?
| | Nanoparticles | 1 | 2013 | 312 | 0.340 |
Why?
| | Students | 1 | 2014 | 499 | 0.330 |
Why?
| | Vaccines | 1 | 2013 | 375 | 0.310 |
Why?
| | Athletic Injuries | 1 | 2014 | 456 | 0.290 |
Why?
| | Endovascular Procedures | 2 | 2022 | 267 | 0.290 |
Why?
| | Hospitalization | 1 | 2016 | 1762 | 0.290 |
Why?
| | Accidental Falls | 2 | 2016 | 151 | 0.230 |
Why?
| | Vaccines, Synthetic | 2 | 2014 | 124 | 0.220 |
Why?
| | Cell Membrane | 3 | 2014 | 670 | 0.200 |
Why?
| | Mechanical Thrombolysis | 1 | 2022 | 5 | 0.200 |
Why?
| | Thrombectomy | 4 | 2022 | 52 | 0.190 |
Why?
| | Arterial Occlusive Diseases | 1 | 2022 | 75 | 0.190 |
Why?
| | Neurologists | 1 | 2021 | 18 | 0.180 |
Why?
| | Law Enforcement | 1 | 2021 | 36 | 0.180 |
Why?
| | Restraint, Physical | 1 | 2021 | 67 | 0.180 |
Why?
| | Motor Cortex | 1 | 2020 | 46 | 0.170 |
Why?
| | Brain Injuries | 2 | 2015 | 459 | 0.170 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2020 | 60 | 0.170 |
Why?
| | Carotid Arteries | 1 | 2021 | 180 | 0.170 |
Why?
| | Gene Expression | 2 | 2014 | 1417 | 0.160 |
Why?
| | Physician's Role | 1 | 2021 | 192 | 0.160 |
Why?
| | Cerebrovascular Circulation | 1 | 2021 | 219 | 0.160 |
Why?
| | Mice, Inbred BALB C | 3 | 2016 | 1144 | 0.150 |
Why?
| | Magnetic Resonance Imaging | 3 | 2022 | 3039 | 0.150 |
Why?
| | Bone Marrow Transplantation | 1 | 2018 | 237 | 0.140 |
Why?
| | Male | 13 | 2022 | 55396 | 0.140 |
Why?
| | Female | 15 | 2022 | 59325 | 0.140 |
Why?
| | Epilepsy, Post-Traumatic | 1 | 2016 | 3 | 0.140 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2016 | 17 | 0.130 |
Why?
| | Immunoglobulin Class Switching | 1 | 2016 | 15 | 0.130 |
Why?
| | Neisseria meningitidis, Serogroup B | 1 | 2016 | 15 | 0.130 |
Why?
| | Sensation Disorders | 1 | 2016 | 31 | 0.130 |
Why?
| | Transport Vesicles | 1 | 2016 | 18 | 0.130 |
Why?
| | Tularemia | 1 | 2016 | 16 | 0.130 |
Why?
| | Francisella tularensis | 1 | 2016 | 19 | 0.130 |
Why?
| | Blood Transfusion | 1 | 2018 | 265 | 0.130 |
Why?
| | Remission Induction | 1 | 2016 | 233 | 0.130 |
Why?
| | Polysaccharides | 1 | 2016 | 78 | 0.130 |
Why?
| | Craniotomy | 1 | 2016 | 68 | 0.130 |
Why?
| | Immunization | 2 | 2016 | 397 | 0.130 |
Why?
| | International Classification of Diseases | 1 | 2016 | 116 | 0.130 |
Why?
| | Community Participation | 1 | 2016 | 112 | 0.120 |
Why?
| | Longitudinal Studies | 3 | 2016 | 2384 | 0.120 |
Why?
| | Adult | 8 | 2021 | 30375 | 0.120 |
Why?
| | Inpatients | 2 | 2015 | 378 | 0.120 |
Why?
| | Humans | 20 | 2022 | 114043 | 0.120 |
Why?
| | Geriatric Assessment | 1 | 2016 | 175 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 2 | 2014 | 613 | 0.120 |
Why?
| | Psychomotor Agitation | 1 | 2015 | 65 | 0.120 |
Why?
| | Young Adult | 4 | 2018 | 10444 | 0.120 |
Why?
| | Hemolysin Proteins | 1 | 2014 | 31 | 0.120 |
Why?
| | Vaccines, Subunit | 1 | 2014 | 41 | 0.120 |
Why?
| | Craniocerebral Trauma | 1 | 2016 | 133 | 0.120 |
Why?
| | Genes, Synthetic | 1 | 1994 | 14 | 0.120 |
Why?
| | Bungarotoxins | 1 | 1994 | 43 | 0.110 |
Why?
| | Triage | 1 | 2016 | 197 | 0.110 |
Why?
| | Probiotics | 1 | 2014 | 48 | 0.110 |
Why?
| | Epitopes | 1 | 2016 | 434 | 0.110 |
Why?
| | Postural Balance | 1 | 2016 | 185 | 0.110 |
Why?
| | Epidemiologic Studies | 1 | 2014 | 57 | 0.110 |
Why?
| | Aged | 7 | 2022 | 18969 | 0.110 |
Why?
| | Immunity, Humoral | 1 | 2014 | 112 | 0.110 |
Why?
| | Middle Aged | 6 | 2022 | 26605 | 0.110 |
Why?
| | Biomimetics | 1 | 2013 | 36 | 0.110 |
Why?
| | Risk Factors | 5 | 2018 | 8614 | 0.110 |
Why?
| | Species Specificity | 1 | 2014 | 541 | 0.110 |
Why?
| | Sleep Wake Disorders | 1 | 2016 | 232 | 0.110 |
Why?
| | Escherichia coli Proteins | 1 | 2014 | 162 | 0.110 |
Why?
| | Immunity, Cellular | 1 | 2014 | 247 | 0.100 |
Why?
| | Adjuvants, Immunologic | 1 | 2013 | 206 | 0.100 |
Why?
| | Depression | 2 | 2016 | 1133 | 0.090 |
Why?
| | Logistic Models | 1 | 2016 | 1829 | 0.090 |
Why?
| | Adolescent | 4 | 2018 | 17800 | 0.090 |
Why?
| | Follow-Up Studies | 2 | 2016 | 4392 | 0.090 |
Why?
| | Schools | 1 | 2014 | 396 | 0.090 |
Why?
| | Thrombolytic Therapy | 2 | 2022 | 117 | 0.090 |
Why?
| | Treatment Outcome | 5 | 2022 | 9049 | 0.090 |
Why?
| | Biocompatible Materials | 1 | 2013 | 372 | 0.080 |
Why?
| | Anxiety | 1 | 2015 | 843 | 0.080 |
Why?
| | Time Factors | 2 | 2016 | 6077 | 0.080 |
Why?
| | Magnetic Resonance Angiography | 1 | 2011 | 221 | 0.080 |
Why?
| | Emergency Service, Hospital | 2 | 2016 | 1815 | 0.080 |
Why?
| | Prognosis | 1 | 2016 | 3315 | 0.080 |
Why?
| | Radiography | 1 | 2011 | 803 | 0.080 |
Why?
| | Aged, 80 and over | 4 | 2021 | 6306 | 0.070 |
Why?
| | Bacteria | 1 | 2014 | 725 | 0.070 |
Why?
| | United States | 4 | 2021 | 12137 | 0.070 |
Why?
| | Canada | 2 | 2021 | 320 | 0.070 |
Why?
| | Brain Concussion | 1 | 2014 | 477 | 0.070 |
Why?
| | Prospective Studies | 4 | 2021 | 6195 | 0.070 |
Why?
| | Rehabilitation Centers | 2 | 2015 | 32 | 0.060 |
Why?
| | Mice | 3 | 2016 | 14841 | 0.060 |
Why?
| | Animals | 5 | 2016 | 31565 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2022 | 12521 | 0.050 |
Why?
| | Age Factors | 2 | 2021 | 2885 | 0.050 |
Why?
| | Incidence | 2 | 2018 | 2314 | 0.050 |
Why?
| | Reperfusion | 1 | 2021 | 35 | 0.050 |
Why?
| | Cerebral Hemorrhage | 1 | 2021 | 96 | 0.040 |
Why?
| | Neck | 1 | 2021 | 85 | 0.040 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 231 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2021 | 204 | 0.040 |
Why?
| | Brain | 1 | 2011 | 2355 | 0.040 |
Why?
| | Transfusion Reaction | 1 | 2018 | 36 | 0.040 |
Why?
| | Cohort Studies | 2 | 2018 | 4883 | 0.040 |
Why?
| | Transplantation, Homologous | 1 | 2018 | 377 | 0.040 |
Why?
| | Age of Onset | 1 | 2018 | 444 | 0.030 |
Why?
| | Hematologic Neoplasms | 1 | 2018 | 136 | 0.030 |
Why?
| | O Antigens | 1 | 2016 | 8 | 0.030 |
Why?
| | Graft vs Host Disease | 1 | 2018 | 212 | 0.030 |
Why?
| | Antigen-Antibody Reactions | 1 | 2016 | 49 | 0.030 |
Why?
| | Glycosylation | 1 | 2016 | 130 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2016 | 384 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 2015 | 108 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1638 | 0.030 |
Why?
| | Chromatography, DEAE-Cellulose | 1 | 1994 | 13 | 0.030 |
Why?
| | Electric Organ | 1 | 1994 | 9 | 0.030 |
Why?
| | Torpedo | 1 | 1994 | 11 | 0.030 |
Why?
| | Snakes | 1 | 1994 | 20 | 0.030 |
Why?
| | Bioengineering | 1 | 2014 | 13 | 0.030 |
Why?
| | Factor Xa | 1 | 1994 | 32 | 0.030 |
Why?
| | Aspartic Acid | 1 | 1994 | 77 | 0.030 |
Why?
| | Alanine | 1 | 1994 | 105 | 0.030 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1994 | 138 | 0.030 |
Why?
| | Trauma Centers | 1 | 2016 | 347 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2018 | 519 | 0.030 |
Why?
| | Point Mutation | 1 | 1994 | 216 | 0.030 |
Why?
| | Injury Severity Score | 1 | 2015 | 472 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1994 | 345 | 0.030 |
Why?
| | Protein Structure, Secondary | 1 | 1994 | 325 | 0.030 |
Why?
| | Linear Models | 1 | 2015 | 768 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1994 | 522 | 0.030 |
Why?
| | Biological Transport | 1 | 2014 | 374 | 0.030 |
Why?
| | Protein Folding | 1 | 1994 | 239 | 0.030 |
Why?
| | Pilot Projects | 1 | 2016 | 1360 | 0.020 |
Why?
| | Cognitive Dysfunction | 1 | 2015 | 282 | 0.020 |
Why?
| | Exercise Therapy | 1 | 2014 | 351 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1994 | 1228 | 0.020 |
Why?
| | Base Sequence | 1 | 1994 | 2114 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1994 | 1981 | 0.020 |
Why?
| | Prevalence | 1 | 2015 | 2247 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1994 | 2783 | 0.020 |
Why?
| | Models, Molecular | 1 | 1994 | 1368 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1381 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 5038 | 0.020 |
Why?
| | Vaccination | 1 | 2016 | 1202 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 2958 | 0.020 |
Why?
| | Infant | 1 | 2018 | 7943 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 9114 | 0.020 |
Why?
| | Child | 1 | 2018 | 18400 | 0.010 |
Why?
|
|
Rosenthal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|